Loading...
Chemical structure of FHD-286

GC64821

FHD-286

Also known as N-[(2S)-1-[[4-[6-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-2-pyridinyl]-1,3-thiazol-2-yl]amino]-3-methoxy-1-oxopropan-2-yl]-1-methylsulfonylpyrrole-3-carboxamide

FHD-286 is a BRG1/BRM ATPase inhibitor for the treatment of BAF-related disorders such as acute myeloid leukemia

ChemicalCAS2671128-05-3MW562.66FormulaC24H30N6O6S2
CAS number
2671128-05-3
Molecular weight
562.66
Formula
C24H30N6O6S2
Solubility
DMSO ： 250 mg/mL (444·32 mM; Need ultrasonic)
InChIKey
JBLQNFBXKOAIHG-FCEWJHQRSA-N
Catalogue number
GC64821
Brand
GLPBIO
Computed properties PubChem CID 156818030 · XLogP 1.3 · TPSA 181 Ų · H-bond donors 2
XLogP
1.3
TPSA
181 Ų
H-bond donors
2
H-bond acceptors
10
Rotatable bonds
9
Heavy atoms
38

SMILES C[C@@H]1CN(C[C@@H](O1)C)C2=CC=CC(=N2)C3=CSC(=N3)NC(=O)[C@H](COC)NC(=O)C4=CN(C=C4)S(=O)(=O)C

Computed descriptors from PubChem (CID 156818030), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.